WELS.DE
Amundi S&P World Health Care Screened UCITS ETF Acc
Global
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 419.5 M
ASSETS UNDER MGMT
18 bp
EXPENSES
Fund Basics
| Inception date | Sep 20, 2022 |
| Regulation | UCITs |
| ISIN | IE0006FM6MI8 |
| Distributions | |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
| ELI LILLY & CO | 11.6 % |
| ABBVIE INC | 6.6 % |
| UNITEDHEALTH GROUP INC | 5.4 % |
| ROCHE HOLDING AG-BR | 4.6 % |
| ASTRAZENECA PLC | 4.3 % |
| MERCK & CO. INC. | 4.1 % |
| NOVARTIS AG | 3.8 % |
| THERMO FISHER SCIENTIFIC INC | 3.7 % |
| AMGEN INC | 3.0 % |
| NOVO NORDISK A/S-B | 2.9 % |
Constituent Breakdown
| Number of holdings | 86 |
| Herfindahl-Hirschman Index | 375 |
| Wgt avg mkt cap (mns) | $257,524 |
| Large cap (>$10bn) | 99.3% |
| Mid cap ($2-10bn) | 0.7% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 100.0% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 67.6 % |
 |
SWITZERLAND | 9.9 % |
 |
BRITAIN | 5.8 % |
 |
JAPAN | 3.9 % |
 |
DENMARK | 3.3 % |
 |
FRANCE | 2.7 % |
 |
IRELAND | 2.5 % |
 |
AUSTRALIA | 1.1 % |
 |
GERMANY | 0.9 % |
 |
NETHERLANDS | 0.7 % |
Historical Performance
Standardized Performance (as of 02/28/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 0.9% | -5.3% | 1.0% | 5.2% | -- | -- | -- | 4.6% |
| Dividend Yield | 0.0% | 0.0% | 0.0% | 0.0% | -- | -- | -- | 0.0% |
| Total Returns | 0.9% | -5.3% | 1.0% | 5.2% | -- | -- | -- | 4.6% | Ann. Volatility | 13.7% | 17.4% | 14.6% | 13.5% | -- | -- | -- | 13.4% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | -0.05 | 0% |
| MSCI EAFE | 0.02 | 0% |
| MSCI Emg Mkts | -0.01 | 0% |
Liquidity Measures
| Avg. volume (000) | 30 |
| ADV traded (mns) | $0 |
| Turnover | 0.1% |
| Avg. Bid/Ask (% of price) | 0.00% |
Technical Indicators
| 30d moving avg. (EMA) | $11.36 |
| Relative strength (RSI) | 53 |
| MACD/Signal | 0.01/0.00 |
| Bollinger Bands (Upper/Lower) | $11.49/$11.16 |
| Short interest (% of AUM) | 0.0% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. WELS.DE |
Expenses vs. WELS.DE |
ALTAR Score™ vs. WELS.DE |
|---|---|---|---|---|
| WELG.DE | Amundi S&P World Health Care Screened UCITS ETF Dist | 100.0% | 0 bp | -0.1% |
| XDWH.DE | Xtrackers MSCI World Health Care UCITS ETF 1C | 78.2% | +7 bp | +0.1% |
| WHCA.L | iShares MSCI World Health Care Sector Advanced UCITS ETF | 71.1% | 0 bp | -0.2% |
| WHCS.AS | iShares MSCI World Health Care Sector Advanced UCITS ETF | 71.1% | 0 bp | +0.0% |
| XUHL.DE | Xtrackers MSCI USA Health Care UCITS ETF 1C | 69.7% | -6 bp | -0.1% |
| XUHC.DE | Xtrackers MSCI USA Health Care UCITS ETF 1D | 69.7% | -6 bp | +0.2% |
| IUHC.L | iShares S&P 500 Health Care Sector UCITS ETF | 68.6% | -3 bp | +0.5% |
| IUHE.AS | iShares S&P 500 Health Care Sector UCITS ETF | 68.6% | 0 bp | +0.5% |
| XDG3.DE | Xtrackers MSCI Global SDG 3 Good Health UCITS ETF 1C | 54.5% | +17 bp | -0.5% |
| HEAL.L | iShares Healthcare Innovation UCITS ETF | 26.2% | +22 bp | -4.1% |
Risk and Returns: WELS.DE vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 4/5/2026
Peer Group Comparison Sample data. Subscribe for access.
Price-to-Earnings
Price-to-Sales
Price-to-Book Value
Price-to-Cash Flow
Price-to-Growth
Dividend Yield
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
6.6%
ALTAR SCORE™
77th
PERCENTILE
OVERWEIGHT
ETFRC RATING
There are 579 funds in the Global Equity category with an average
ALTAR Score™ of 4.6% and a standard deviation
of 2.7%. WELS.DE's ALTAR Score™ is approximately 0.7 standard
deviations above the category average. This places WELS.DE in the 77th percentile
among funds in the category.
Sell-Side Consensus
$13.25
PRICE TARGET
+22.5%
UPSIDE